Clinical management patterns of advanced and metastatic gastro‐oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom-Reference-Cited by-同舟云学术

Clinical management patterns of advanced and metastatic gastro‐oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom

Published:2019-12-27 Issue:2 Volume:29 Page:
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Brown Jacqueline¹,Liepa Astra M.²,Bapat Bela³,Madhwani Shweta³,Lorenzen Sylvie⁴,García‐Foncillas Jesús⁵,Candrilli Sean D.³,Kaye James A.⁶

Affiliation:

1. Eli Lilly and Company Surrey UK

2. Eli Lilly and Company Indianapolis IN USA

3. RTI Health Solutions Research Triangle Park NC USA

4. Department of hematology and oncology Klinikum rechts der Isar der TU München München Germany

5. Cancer Institute University Hospital Fundacion Jimenez Diaz, Autonomous University Madrid Spain

6. RTI Health Solutions Waltham MA USA

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ecc.13213

Reference23 articles.

1. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

2. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5

3. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

4. Cancer Today. (2018). Retrieved fromhttp://gco.iarc.fr/today/home

5. Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer;Gastric Cancer;2023-10-17